Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-06-24
1996-07-23
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 111, 536 41, 53612313, 536121, 536122, 552203, A61K 3170, C07H 500
Patent
active
055389546
ABSTRACT:
A salt of sucrose-octa-O-sulfonic acid and a tetracycline useful in inhibiting protein synthesis of bacteria.
REFERENCES:
patent: 3200149 (1965-08-01), Blackwood et al.
patent: 3432489 (1969-03-01), Nitta et al.
patent: 3927094 (1975-12-01), Villax
patent: 5143934 (1992-09-01), Ladiing et al.
Richard S. Berger, MD.; "A Double-Blind, Multiple-Dose, Placebo-Controlled, Cross-Over Study to Compare the Incidence of Gastrointestinal Complaints in Healthy Subjects Given Doryx R and Vibramycin R"; J. Clin. Pharmacol; 28:367-370 (1988).
Joseph B. Bogardus; "Dissolution Rates of Doxycyline Free Base and Hydrochloride Salts"; Journal of Pharmaceutical Sciences; vol. 68; No. 9; pp. 1183-1184 (Sep. 1979).
Burke A. Cunha et al.; "Doxycyline"; Therapeutic Drug Monitoring; 4:115-135 (1982).
Georges Delpre, MD et al.; "Induction of Esophageal Injuries by Doxycycline and Other Pills"; Digestive Diseases and Sciences; vol. 34, No. 5; pp. 797-800 (May 1989).
Milo Gibaldi; "Pharmacokinetics of Absorption and Elimination of Doxcycline in Man"; Chemotherapia; vol. 12; No. 5; pp. 265-271 (1967).
A. Grahnen, Ph.D. et al.; "Effect of Increasing Gastric pH on the Relative Bioavailability of Doxycycline Carrageenate Tablets 100 MG (Kabi Pharmacia) in Comparison with Vibramycin.RTM.Novum Tablets 100 MG (Pfizer)"; Final Report; (Aug. 1991).
Anna-Stina Malmborg; "Bioavailability of Doxycycline Monohydrate"; Chemotherapy; 30:76-80 (1984).
Hideki Morikawa et al.; "Structural Analysis of the Amorphous Sodium Salt and Aluminium Hydroxide Salt of Sucrose Sulphate"; J Chem. Soc.; 77:629-639 (1981).
Renpei Nagashima, Ph. D.; "Mechanisms of Action of Sucralfate"; J. of Clin. Gastroenterology; 3 (suppl. 2):117-127 (1981).
Vu X. Nguyen et al.; "Effect of Oral Antacid Administration on the Pharmacokinetics of Intravenous Doxycycline"; Antimicrob. Agents Chemother.; vol. 33; No. 4; pp. 435-436 (Apr. 1989).
Kiyoshige Ochi et al.; "Crystalline Salts of Sucrose Octasulfate"; Chem. Pharm. Bull.; 28(2):638-641 (1980).
S. Saivin et al.; "Clinical Pharmacokinetics of Doxycyline and Minocycline"; Clinical Pharmacokinetics; 15:355-366 (1988).
M. Schach von Wittenau; "A Symposium on Doxycycline: Pharmacokinetics of Doxycycline"; OPMSAZ; 33:5-10 (1974).
M. J. Story et al.; "Doxycycline Tolerance Study: Incidence of Nausea after doxycycline administration to healthy volunteers: A comparison of 2 formulations (Doryx'vs vibramycin')"; Eur. J. Clin. Pharmacol; 40:419-421 (1991).
Desmond B. Williams et al.; "Absorption of Doxycycline from a Controlled Release Pellet Formulation: The Influence of Food on Bioavailability"; Biopharmaceutics & Drug Disposition; vol. 11; pp. 93-105 (1990).
Dyrsting Hjarne
Koch Torben
A/S Dumex (Dumex Ltd.)
Peselev Elli
LandOfFree
Salts of tetracyclines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Salts of tetracyclines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of tetracyclines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713100